Edge Medical Repurchases 300,000 H Shares for HKD 9.99 Million, Cutting Free Float by 0.09%

Bulletin Express10-28

Shenzhen Edge Medical Co., Ltd. (Edge Medical) disclosed that it bought back 300,000 H shares on 28 October 2026 via on-market transactions on the Hong Kong Stock Exchange. The repurchase was executed within a price range of HKD 32.76 to HKD 33.50 per share, translating into a volume-weighted average price of HKD 33.30 and an aggregate consideration of HKD 9.99 million.

Following the transaction, the company’s outstanding shares (excluding treasury stock) declined by 0.09% to 323.52 million, while treasury shares increased to 4.24 million. Total issued shares remained unchanged at 327.76 million, as the repurchased shares were retained in treasury.

The buy-back forms part of the repurchase mandate approved on 25 June 2026, under which Edge Medical is authorised to acquire up to 32.61 million shares. Cumulatively, the company has now repurchased 2.62 million shares, representing 0.80% of the issued share capital on the mandate date.

In line with Hong Kong listing rules, Edge Medical is subject to a moratorium on issuing, selling or transferring any shares or treasury shares until 27 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment